NeuroMetrix, Nipro Diagnostics form diabetes deal

NeuroMetrix Inc. (Nasdaq: NURO) said it will enter into a partnership with Ft. Lauderdale, Fla.-based Nipro Diagnostics to advance a test for diabetic peripheral neuropathy. Terms of the deal were not disclosed.

Waltham-based NeuroMetrix today said the collaboration would evaluate opportunities for its product, called NC-stat DPNCheck, to be sold in retail medical clinics, such as at drug stores.